556 related articles for article (PubMed ID: 16104669)
21. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
Christiansen M; Høgdall EV; Larsen SO; Høgdall C
Prenat Diagn; 2002 May; 22(5):385-7. PubMed ID: 12001192
[TBL] [Abstract][Full Text] [Related]
22. [Prenatal screening for major fetal defects by using of maternal serum markers].
Bao P; Wu Y; Gu Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):649-51. PubMed ID: 9639762
[TBL] [Abstract][Full Text] [Related]
23. Clinical application of inhibin a measurement: prenatal serum screening for Down syndrome.
Lambert-Messerlian GM; Canick JA
Semin Reprod Med; 2004 Aug; 22(3):235-42. PubMed ID: 15319826
[TBL] [Abstract][Full Text] [Related]
24. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Palomaki GE; Neveux LM; Knight GJ; Haddow JE
Prenat Diagn; 2003 Mar; 23(3):243-7. PubMed ID: 12627428
[TBL] [Abstract][Full Text] [Related]
25. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters.
Cuckle H; Benn P; Wright D
Semin Perinatol; 2005 Aug; 29(4):252-7. PubMed ID: 16104677
[TBL] [Abstract][Full Text] [Related]
26. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
27. Medically assisted reproduction and second-trimester maternal serum marker screening for Down syndrome.
Muller F; Dreux S; Lemeur A; Sault C; Desgrès J; Bernard MA; Giorgetti C; Lemay C; Mirallié S; Beauchet A;
Prenat Diagn; 2003 Dec; 23(13):1073-6. PubMed ID: 14691995
[TBL] [Abstract][Full Text] [Related]
28. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome.
Huang T; Hoffman B; Meschino W; Kingdom J; Okun N
Prenat Diagn; 2010 May; 30(5):471-7. PubMed ID: 20440736
[TBL] [Abstract][Full Text] [Related]
29. Second-trimester dimeric inhibin-A in Down's syndrome screening.
Spencer K; Wallace EM; Ritoe S
Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
[TBL] [Abstract][Full Text] [Related]
30. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
31. An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years.
Biggio JR; Morris TC; Owen J; Stringer JS
Am J Obstet Gynecol; 2004 Mar; 190(3):721-9. PubMed ID: 15042005
[TBL] [Abstract][Full Text] [Related]
32. Stability of first- and second-trimester serum markers after storage and shipment.
Lambert-Messerlian GM; Eklund EE; Malone FD; Palomaki GE; Canick JA; D'Alton ME
Prenat Diagn; 2006 Jan; 26(1):17-21. PubMed ID: 16378319
[TBL] [Abstract][Full Text] [Related]
33. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
34. Second-trimester maternal serum markers in twin pregnancy with complete mole: report of 2 cases.
Lambert-Messerlian G; Pinar H; Rubin LP; De Paepe ME; Tantravahi U; Steinhoff MM; Russell M; Canick JA
Pediatr Dev Pathol; 2005; 8(2):230-4. PubMed ID: 15765203
[TBL] [Abstract][Full Text] [Related]
35. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
MacDonald ML; Wagner RM; Slotnick RN
Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
[TBL] [Abstract][Full Text] [Related]
37. Early detection of preeclampsia using inhibin a and other second-trimester serum markers.
Ree PH; Hahn WB; Chang SW; Jung SH; Kang JH; Cha DH; Kang MS; Huh JY
Fetal Diagn Ther; 2011; 29(4):280-6. PubMed ID: 21252475
[TBL] [Abstract][Full Text] [Related]
38. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
Palomaki GE; Wright DE; Summers AM; Neveux LM; Meier C; O'donnell A; Huang T; Knight GJ; Haddow JE
Prenat Diagn; 2006 Aug; 26(8):730-9. PubMed ID: 16810709
[TBL] [Abstract][Full Text] [Related]
39. Cross-trimester marker ratios in prenatal screening for Down syndrome.
Wald NJ; Bestwick JP; Morris JK
Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
[TBL] [Abstract][Full Text] [Related]
40. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
